• Reuters

  • SHARE

U.S. health officials said on Tuesday the first clinical trial testing Gilead Sciences Inc.’s experimental antiviral drug, remdesivir, in hospitalized patients with the coronavirus has started.

The first trial participant is an American who was repatriated after being quarantined on the Diamond Princess cruise ship and the study is being conducted at the University of Nebraska Medical Center in Omaha, according to the National Institutes of Health.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

Your news needs your support

Since the early stages of the COVID-19 crisis, The Japan Times has been providing free access to crucial news on the impact of the novel coronavirus as well as practical information about how to cope with the pandemic. Please consider subscribing today so we can continue offering you up-to-date, in-depth news about Japan.